ClinicalTrials.Veeva
Menu

Find clinical trials for Eczema in Orlando, FL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Dermatitis
Atopic Dermatitis
Skin Diseases
Dyssomnias
Food Hypersensitivity
Hypersensitivity
Parasomnias

Eczema trials near Orlando, FL, USA:

A Study of (LY3650150) Lebrikizumab to Assess the Safety and Efficacy of Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis and Skin of Color (ADmirable)

The main purpose of this study is to determine the safety and efficacy lebrikizumab in adolescent and adult participants with moderate-to-severe atop...

Active, not recruiting
Atopic Dermatitis
Drug: Lebrikizumab

Phase 3

Lilly
Lilly

Orlando, Florida, United States and 36 other locations

This is a phase IIa, randomized, double-blind, placebo-controlled, multi-center proof-of-concept (POC) study in subjects with moderate to severe Atop...

Enrolling
Atopic Dermatitis
Drug: ADX-914
Drug: Placebo

Phase 2

Q32 Bio

Orlando, Florida, United States and 39 other locations

The purpose of this study is to learn about the safety and effects of 2 study medicines (PF-07275315 and PF-07264660) for the treatment of atopic der...

Enrolling
Atopic Dermatitis
Drug: PF-07264660
Drug: PF-07275315

Phase 2

Pfizer
Pfizer

Orlando, Florida, United States and 53 other locations

B7451015 is a Phase 3 study to evaluate Abrocitinib with or without Topical Medications in patients aged 12 years and older who have moderate to seve...

Active, not recruiting
Dermatitis, Atopic
Drug: Abrocitinib 200 mg
Drug: Abrocitinib 100 mg

Phase 3

Pfizer
Pfizer

Orlando, Florida, United States and 557 other locations

The primary objective of the study is to evaluate the pharmacokinetics (PK) of multiple cytochrome P450 (CYP450) substrates alone and in combination...

Active, not recruiting
Atopic Dermatitis
Drug: Omeprazole
Drug: Metoprolol

Early Phase 1

Amgen
Amgen

DeLand, Florida, United States of America and 6 other locations

This is a randomized, double-blind, placebo-controlled, single- and multiple ascending dose study of subcutaneous (SC) administration of NM26-2198 in...

Enrolling
Atopic Dermatitis
Other: Placebo
Biological: NM26-2198

Phase 1

Numab Therapeutics

DeLand, Florida, United States and 21 other locations

The purpose of the study is to investigate the safety and tolerability of single-ascending doses of UCB1381 (intravenous and subcutaneous) in healthy...

Enrolling
Atopic Dermatitis
Drug: Placebo
Biological: UCB1381

Phase 1, Phase 2

UCB
UCB

DeLand, Florida, United States and 23 other locations

This is a Phase 3, open-label study to evaluate the long-term safety of difamilast ointment 1% in subjects ≥2 years of age with mild to moderate AD....

Active, not recruiting
Atopic Dermatitis
Drug: Difamilast

Phase 3

Acrotech Biopharma
Acrotech Biopharma

Orlando, Florida, United States and 62 other locations

The main purpose of this study is to describe the efficacy and safety of LY3454738 in adult participants with moderate-to-severe atopic dermatitis (A...

Enrolling
Atopic Dermatitis
Drug: Placebo
Drug: LY3454738

Phase 2

Lilly
Lilly

Winter Park, Florida, United States of America and 66 other locations

The primary objective of this study is to describe the safety and tolerability of rocatinlimab in adolescents with moderate-to-severe AD.

Active, not recruiting
Atopic Dermatitis
Drug: Rocatinlimab

Phase 3

Amgen
Amgen

Kissimmee, Florida, United States and 76 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems